FDA warnings

U.S. health regulators said on Friday they do not expect any shortage of children’s pain and allergy medications despite Johnson… »   

Britain’s health cost watchdog has rejected Roche’s Tarceva pill for long-term use in lung cancer patients who have had treatment… »   

U.S. health officials will post summaries of risks from recently approved medicines on a government website in an effort to… »   

In another burst of bad publicity for Johnson & Johnson, the company on Tuesday said it has recalled four… »   

An unpublished study by a Food and Drug Administration researcher and colleagues at Medicare indicates that as many as 48,000… »   

The Food and Drug Administration said Friday that it will investigate the possible increased risk of heart attacks, stroke or… »   

Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein… »   

The U.S. Food and Drug Administration is looking into whether Daiichi Sankyo’s blood pressure medicine Benicar increases the risk of… »   

The diabetes drug Avandia, known generically as rosiglitazone, exposed patients to greater health risks including heart attacks, and even death,… »   

U.S. health regulators have finalized new warnings for controversial inhaled asthma drugs.

The warnings, expected since February, say medicines… »   

Weight-loss drugs Xenical and Alli will carry new warnings about rare reports of liver injury, U.S. health officials said Wednesday.

U.S. health regulators are investigating hundreds of reported complications with dozens of recalled children’s medications made by Johnson & Johnson… »   

An major trial of Avandia puts patients at risk and should be stopped, a U.S. advocacy group said on Tuesday… »